Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary arterial hypertension is a rare and life‐shortening condition often diagnosed at an advanced stage. Despite increased awareness, the delay to diagnosis remains unchanged. This study explores whether a predictive model based on healthcare resource utilisation can be used to screen large populations to identify patients at high risk of idiopathic pulmonary arterial hypertension. Hospital Episode Statistics from the National Health Service in England, providing close to full national coverage, were used as a measure of healthcare resource utilisation. Data for patients with idiopathic pulmonary arterial hypertension from the National Pulmonary Hypertension Service in Sheffield were linked to pre‐diagnosis Hospital Episode Statistics records. A non‐idiopathic pulmonary arterial hypertension control cohort was selected from the Hospital Episode Statistics population. Patient history was limited to ≤5 years pre‐diagnosis. Information on demographics, timing/frequency of diagnoses, medical specialities visited and procedures undertaken was captured. For modelling, a bagged gradient boosting trees algorithm was used to discriminate between cohorts. Between 2008 and 2016, 709 patients with idiopathic pulmonary arterial hypertension were identified and compared with a stratified cohort of 2,812,458 patients classified as non‐idiopathic pulmonary arterial hypertension with ≥1 ICD‐10 coded diagnosis of relevance to idiopathic pulmonary arterial hypertension. A predictive model was developed and validated using cross‐validation. The timing and frequency of the clinical speciality seen, secondary diagnoses and age were key variables driving the algorithm’s performance. To identify the 100 patients at highest risk of idiopathic pulmonary arterial hypertension, 969 patients would need to be screened with a specificity of 99.99% and sensitivity of 14.10% based on a prevalence of 5.5/million. The positive predictive and negative predictive values were 10.32% and 99.99%, respectively. This study highlights the potential application of artificial intelligence to readily available real‐world data to screen for rare diseases such as idiopathic pulmonary arterial hypertension. This algorithm could provide low‐cost screening at a population level, facilitating earlier diagnosis, improved diagnostic rates and patient outcomes. Studies to further validate this approach are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationBig data and machine learning algorithms for health-care delivery
Ngiam, K. Y., & Khor, I. W. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30149-4 · Cited by 1,424
Machine Learning and Prediction in Medicine — Beyond the Peak of Inflated Expectations
Chen, J. H., & Asch, S. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1702071 · Cited by 1,171
Pulmonary Arterial Hypertension: The Clinical Syndrome
Lai, Y.-C., Potoka, K. C., Champion, H. C., Mora, A. L., & Gladwin, M. T. (2014) · Circulation Research · doi:10.1161/circresaha.115.301146 · Cited by 402
Cited by
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Self-citation2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Self-citationKumar, Y., Koul, A., Singla, R., & Ijaz, M. F. (2023) · Journal of Ambient Intelligence and Humanized Computing · doi:10.1007/s12652-021-03612-z · Cited by 1,040
“Kiely et al. (2019) investigated the prescient model dependent on the medical care assets that could be sued to screen huge populaces to distinguish the patients at great danger of pneumonic blood vessel hypertension.”
BackgroundRetractedMannuru, N. R., Shahriar, S., Teel, Z. A., Wang, T., Lund, B. D., Tijani, S., Pohboon, C. O., Agbaji, D., Alhassan, J., Galley, J., et al. (2025) · Information Development · doi:10.1177/02666669231200628 · Cited by 314
Maassen, O., Fritsch, S., Palm, J., Deffge, S., Kunze, J., Marx, G., Riedel, M., Schuppert, A., & Bickenbach, J. (2021) · Journal of Medical Internet Research · doi:10.2196/26646 · Cited by 125
Metadata
- Authors
- Kiely, D. G., Doyle, O., Drage, E., Jenner, H., Salvatelli, V., Daniels, F. A., Rigg, J., Schmitt, C., Samyshkin, Y., Lawrie, A., & Bergemann, R.
- Venue
- Pulmonary Circulation
- Publisher
- Wiley
- Published
- 2019-10
- Volume
- 9
- Issue
- 4
- Pages
- 1-9
- ISSN
- 2045-8932 (ISSN-L)
- 2045-8940
- OpenAlex
- W2987738008
- Cited by
- 62
- References
- 4
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension. https://app.cochat.ai/papers/10.1177/2045894019890549
- The paper
- Kiely, D. G., Doyle, O., Drage, E., Jenner, H., Salvatelli, V., Daniels, F. A., Rigg, J., Schmitt, C., Samyshkin, Y., Lawrie, A., & Bergemann, R. (2019). Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension. Pulmonary Circulation. https://doi.org/10.1177/2045894019890549
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.